Gastroparesis Clinical Trials

47 recruitingLast updated: June 18, 2026

There are 47 actively recruiting gastroparesis clinical trials across 12 countries. Studies span Not Applicable, Phase 1, Phase 3, Early Phase 1, Phase 2. Top locations include Indianapolis, Indiana, United States, Louisville, Kentucky, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Gastroparesis Trials at a Glance

47 actively recruiting trials for gastroparesis are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Indianapolis, Louisville, and Philadelphia. Lead sponsors running gastroparesis studies include Indiana University, Johns Hopkins Bloomberg School of Public Health, and Enterra Medical, Inc..

Browse gastroparesis trials by phase

Treatments under study

About Gastroparesis Clinical Trials

Looking for clinical trials for Gastroparesis? There are currently 42 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastroparesis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastroparesis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 47 trials

Recruiting

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

GastroparesisFunctional Dyspepsia
University of Auckland, New Zealand125 enrolled3 locationsNCT06854120
Recruiting
Not Applicable

Effect of Gastric Electrical Stimulation on Serum Insulin Levels

Gastroparesis Nondiabetic
Indiana University32 enrolled2 locationsNCT07635576
Recruiting
Not Applicable

Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)

GastroparesisFunctional Dyspepsia
Wake Forest University Health Sciences10 enrolled1 locationNCT06732453
Recruiting

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

Gastroparesis
University of Louisville3,000 enrolled1 locationNCT03876288
Recruiting
Not Applicable

Acupuncture for Postoperative Gastric Emptying Delay

Delayed Gastric Emptying Following ProcedureGastroparesis Postoperative
Qilu Hospital of Shandong University176 enrolled1 locationNCT07505927
Recruiting
Early Phase 1

Growth Hormone for the Treatment of Gastroparesis

Gastroparesis
Mayo Clinic10 enrolled2 locationsNCT06803589
Recruiting
Phase 3

Domperidone in Treating Patients With Gastrointestinal Disorders

Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting

Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

GastroparesisDiabetic GastroparesisIdiopathic Gastric Motility Disorder
Johns Hopkins Bloomberg School of Public Health150 enrolled5 locationsNCT04661215
Recruiting

GpCRC Pediatric Gastroparesis Registry 2

GastroparesisGastroparesis-like Syndrome
Johns Hopkins Bloomberg School of Public Health216 enrolled6 locationsNCT05981300
Recruiting

Gastroparesis Registry 4

Gastro-Intestinal DisorderGastroparesisGastroparesis Nondiabetic+3 more
Johns Hopkins Bloomberg School of Public Health250 enrolled6 locationsNCT05846802
Recruiting

Study of Gastric Motility in Eosinophilic Gastritis

GastroparesisEosinophilic GastritisGastric Motility Disorder
Children's Hospital Medical Center, Cincinnati30 enrolled3 locationsNCT05229432
Recruiting
Not Applicable

Compassionate Use of Domperidone for Refractory Gastroparesis

GastroparesisGastroesophageal RefluxGERD
Jose Cocjin20 enrolled1 locationNCT04699591
Recruiting

Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy

Esophageal CancerGastroparesisGastric Cancer Stage
Zhejiang University5,000 enrolled3 locationsNCT07104214
Recruiting

Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis

Gastroparesis
Indiana University75 enrolled1 locationNCT04434781
Recruiting
Not Applicable

The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

Gastroparesis
Indiana University20 enrolled1 locationNCT06493032
Recruiting
Not Applicable

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Type 1 DiabetesGastroparesis Due to Diabetes Mellitus Type I
Viral N. Shah34 enrolled1 locationNCT07287943
Recruiting

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

Diabetic Gastroparesis
Northern Jiangsu People's Hospital50 enrolled1 locationNCT07324785
Recruiting

BSGM to Evaluate Patients With GI Symptoms

Functional Gastrointestinal DisordersGastroparesisDyspepsia and Other Specified Disorders of Function of Stomach+1 more
Children's Hospital of Philadelphia685 enrolled5 locationsNCT05880199
Recruiting

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

achalasiaZenker DiverticulumGastroparesis+2 more
AdventHealth600 enrolled1 locationNCT05905016
Recruiting
Not Applicable

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

GastroparesisDyspepsia
Massachusetts General Hospital65 enrolled1 locationNCT03603730